Plus   Neg

Haemonetics Corp. (HAE) Is Challenging The Highs After Q3 Earnings Beat

Haemonetics Corp. (HAE) reported third quarter EPS of $0.62 Tuesday morning, up from $0.43 in the previous year. Analysts expected EPS of $0.44.

The company now expects full year 2018 adjusted EPS of $1.80 to $1.90, compared to the previous outlook of $1.65 to $1.75. Analysts expect EPSof $1.70.

Haemonetics gapped open sharply higher Tuesday morning and is now up 6.19 at $66.91. The stock is now challenging the upper end of a 1-month trading range at the highs of the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Intraday Alerts

0 Articles
Follow RTT